期刊名称：PLOS GENETICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About PLoS Genetics
PLoS Genetics (eISSN 1553-7404, ISSN 1553-7390) is an open-access, peer-reviewed journal published weekly by the Public Library of Science (PLoS).
PLoS Genetics is run by an international Editorial Board, headed by the Editor-in-Chief, Wayne Frankel (The Jackson Laboratory, Bar Harbor, Maine, United States).
Articles published in PLoS Genetics are deposited in PubMed Central and cited in PubMed.
Scope
Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.
PLoS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, cancer biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.
Please refer to our Author Guidelines when you are preparing your manuscripts for submission. If you are unsure whether your paper is suitable for PLoS Genetics, you can send a Presubmission Inquiry.
Features
- Weekly Primary Research Articles—high-quality, original contributions from a broad sweep of international researchers
- Reviews—these invited pieces summarize particularly interesting, hot, or forward-looking aspects of genetics or genomics research from the authors?unique perspective
- Interviews, now accompanied by video clips—by Jane Gitschier, Interviews Editor
- Special Reports—these occasional articles include short and engaging conference reports
- Correspondence—up to 600 words in length and cited in PubMed
- Reader Responses—up to 750 words, promoting dialogue and shared information within the community
Open Access
All works published in PLoS journals are open access, licensed under the Creative Commons Attribution License. Everything is immediately available online without cost to anyone, anywhere—to read, download, redistribute, include in databases, and otherwise use—subject only to the condition that the original authorship is properly attributed. Copyright is retained by the author.
Publication Charges
To provide open access, PLoS journals use a business model in which our expenses—including those of peer review, journal production, and online hosting and archiving—are recovered in part by charging a publication fee to the authors or research sponsors for each article they publish. For PLoS Genetics the publication fee is US$2100. Authors who are affiliated with one of our Institutional Members are eligible for a discount on this fee.
We offer a complete or partial fee waiver for authors who do not have funds to cover publication fees. Editors and reviewers have no access to payment information, and hence inability to pay will not influence the decision to publish a paper.
For further information, see our Publication Fee FAQ.
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information about PLoS, visit www.plos.org.
Instructions to Authors
The techniques of genetics and genomics are being applied to a wealth of biological questions and experimental systems. PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology. With immediate free access to all content, PLoS Genetics provides a unique venue for publishing genetics and genomics research, ensuring that authors reach the widest possible audience.
PLoS Genetics publishes human studies as well as research on model organisms—from mice and flies, to plants and bacteria. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, genetics of disease and disease models, gene therapy, cancer biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics. PLoS Genetics welcomes research articles that demonstrate a novel methodological advance.
To provide open access, PLoS journals use a business model in which our expenses—including those of peer review, journal production, and online hosting and archiving—are recovered in part by charging a publication fee to the authors or research sponsors for each article they publish. For PLoS Genetics the publication fee is US$2100. Authors who are affiliated with one of our Institutional Members are eligible for a discount on this fee.
We offer a complete or partial fee waiver for authors who do not have funds to cover publication fees. Editors and reviewers have no access to payment information, and hence inability to pay will not influence the decision to publish a paper.
For further information, see our Publication Fee FAQ.
2. Criteria for Publication
To be considered for publication in PLoS Genetics, any given manuscript must satisfy the following criteria:
- Originality
- High importance to researchers in the field
- Broad interest to researchers in genetics and genomics
- Rigorous methodology
- Substantial evidence for its conclusions
3. Overview of the Editorial Process
Our aim is to provide all authors with an efficient, courteous, and constructive editorial process. To achieve its required level of quality, PLoS Genetics is highly selective in the manuscripts that it publishes; rejection rates are high. To ensure the fairest and most objective decision-making, the editorial process is run as a partnership between the PLoS Genetics Editor-in-Chief (EIC), a team of Selection Editors, and a group of academic experts who act as Associate Editors (AEs). These individuals are leaders in their fields and represent the full breadth of genetics and genomics.
Submitted manuscripts are assigned to an AE by the EIC or by one of the Section Editors. The AE is most often a member of the PLoS Genetics Editorial Board but occasionally a guest of the Board is invited to serve in this capacity. The AE evaluates the paper and decides whether it describes a sufficient body of work to support a major advance in a particular field. If so, the paper is sent out for external peer review.
Expert reviewers assess the technical and scientific merits of the work. Once all reviews have been received and considered by the editors, a decision letter to the corresponding author is drafted.
Possible decisions include:
4. Presubmission Inquiries
When authors are unsure whether their work satisfies the basic requirements for consideration at PLoS Genetics, we are happy to receive presubmission inquiries. If you would like to submit an informal presubmission inquiry to see if a manuscript is appropriate in principle, please login or register for a new account within our online submission system, choosing 'Submit Presubmission Inquiry' from the list of Author Tasks.
Responses to these inquiries are normally provided within two or three working days. Responses may take longer if consultation between members of the editorial board is required. If you are invited to submit your manuscript online, we will do our best to provide an expeditious initial assessment of the complete manuscript for suitability and then, if warranted, external peer review.
5. Preparation of Research Manuscripts
PLoS Genetics considers manuscripts of any length; we encourage the submission of both substantial full-length bodies of work and shorter manuscripts that report novel findings that might be based on a more limited range of experiments. The work must demonstrate its novelty, its importance to a particular field, its biological significance, and conclusions that are justified by the study.
The writing style should be concise and accessible. Editors may make suggestions for how to achieve this, as well as suggestions for cuts or additions that could be made to the article to strengthen the argument. Our aim is to make the editorial process rigorous and consistent, but not intrusive or overbearing. Authors are encouraged to use their own voice and to decide how best to present their ideas, results, and conclusions.
Although we encourage submissions from around the globe, we require that manuscripts be submitted in English. As a step towards overcoming language barriers, we encourage authors fluent in other languages to provide copies of their full articles or abstracts in other languages. Translations should be submitted as supporting information and listed, together with other supporting information files, at the end of the article text.
Organization of the Manuscript
Most articles published in PLoS Genetics are organized into the following sections: Title, Authors, Affiliations, Abstract, Introduction, Results, Discussion, Materials and Methods, Acknowledgments, , and Figure Legends. Uniformity in format facilitates the experience of readers and users of the journal. To provide flexibility, however, authors are also able to include the Materials and Methods section before the Results section or before the Discussion section. Please also note that the Results and Discussion can be combined into one Results/Discussion section. Abstracts should not exceed 250-300 words. There are no specific length restrictions for the remaining sections of the manuscript; however, we urge authors to present and discuss their findings concisely.
Our submission system supports a limited range of formats for text and graphics. If you experience difficulties with the manuscript submission Web site or are concerned about the suitability of your files, please contact the journal office (plosgenetics [at] plos.org).
Title (75 characters or less)
The title should be specific to the project, yet concise. It should be comprehensible to readers outside your field. Avoid specialist abbreviations, if possible. Titles should be presented in title case, meaning that all words except for prepositions, articles, and conjunctions should be capitalized.
Example:
Detection of Specific Sequences among DNA Fragments Separated by Gel Electrophoresis. Please also provide a brief "running head" of no more than 40 characters.
Authors and Affiliations
Provide the first names or initials (if used), middle names or initials (if used), surnames, and affiliations—department, university or organization, city, state/province (if applicable), and country—for all authors. One of the authors should be designated as the corresponding author. It is the corresponding author’s responsibility to ensure that the author list, and the summary of the author contributions to the study are accurate and complete. If the article has been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the Acknowledgments.
Abstract
The abstract succinctly introduces the paper; it should not exceed 250-300 words. It should mention the techniques used without going into methodological detail and should summarize the most important results. The abstract is conceptually divided into the following three sections: Background, Methodology/Principal Findings, and Conclusions/Significance. Please do not include any citations in the abstract. Avoid specialist abbreviations.
Introduction
The introduction should put the focus of the manuscript into a broader context. As you compose the introduction, think of readers who are not experts in this field. Include a brief review of the key literature. If there are relevant controversies or disagreements in the field, they should be mentioned so that a non-expert reader can delve into these issues further. The introduction should conclude with a brief statement of the overall aim of the experiments and a comment about whether that aim was achieved.
Results
The results section should provide details of all of the experiments that are required to support the conclusions of the paper. There is no specific word limit for this section, but details of experiments that are peripheral to the main thrust of the article and that detract from the focus of the article should not be included. The section may be divided into subsections, each with a concise subheading. Large datasets, including raw data, should be submitted as supporting files; these are published online alongside the accepted article. The results section should be written in past tense.
Discussion
The discussion should spell out the major conclusions of the work along with some explanation or speculation on the significance of these conclusions. How do the conclusions affect the existing assumptions and models in the field? How can future research build on these observations? What are the key experiments that must be done? The discussion should be concise and tightly argued. The results and discussion may be combined into one section, if desired.
Materials and Methods
This section should provide enough detail for reproduction of the findings. Protocols for new methods should be included, but well-established protocols may simply be referenced. We encourage authors to submit, as separate supporting information files, all appendices, detailed protocols, or details of the algorithms for newer or less well-established methods. These are published online only, but are linked to the article and are fully searchable.
Acknowledgments
People who contributed to the work, but do not fit the criteria for authors should be listed in the Acknowledgments, along with their contributions. You must also ensure that anyone named in the acknowledgments agrees to being so named.
Funding
This section should describe sources of funding that have supported the work. Please also describe the role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit it for publication.
References
Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. Limited citation of unpublished work should be included in the body of the text only. All personal communications should be supported by a letter from the relevant authors.
PLoS uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. Where there are more than three sequential citations, they should be given as a range. Example: "...has been shown previously [1,4?,22]." Make sure the parts of the manuscript are in the correct order for the relevant journal before ordering the citations. Figure captions and tables should be at the end of the manuscript.
Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. For all references, list the first five authors; add "et al." if there are additional authors. You can include a DOI number for the full-text article as an alternative to or in addition to traditional volume and page numbers. Please use the following style for the reference list:
Published Papers
1. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74: 5463?467.
Accepted Papers
Same as above, but "In press" appears instead of the page numbers. Example: Adv Clin Path. In press.
Electronic Journal Articles 1. Loker WM (1996) "Campesinos" and the crisis of modernization in Latin America. Jour Pol Ecol 3. Available: http://www.library.arizona.edu/ej/jpe/volume_3/ascii-lokeriso.txt. Accessed 11 August 2006.
Books
1. Bates B (1992) Bargaining for life: A social history of tuberculosis. Philadelphia: University of Pennsylvania Press. 435 p.
Book Chapters
1. Hansen B (1991) New York City epidemics and history for the public. In: Harden VA, Risse GB, editors. AIDS and the historian. Bethesda: National Institutes of Health. pp. 21?8.
Accession Numbers
All appropriate datasets, images, and information should be deposited in public resources. Please provide the relevant accession numbers (and version numbers, if appropriate). Suggested databases include, but are not limited to:
In addition, as much as possible, please provide accession numbers or identifiers for all entities such as genes, proteins, mutants, diseases, etc., for which there is an entry in a public database, for example:
Providing accession numbers allows linking to and from established databases and integrates your article with a broader collection of scientific information. Please list all accession numbers directly after the Supporting Information section.
Abbreviations
Please keep abbreviations to a minimum. List all non-standard abbreviations in alphabetical order, along with their expanded form. Define them as well upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.
Nomenclature
The use of standardized nomenclature in all fields of science and medicine is an essential step toward the integration and linking of scientific information reported in published literature. We will enforce the use of correct and established nomenclature wherever possible:
- We strongly encourage the use of SI units. If you do not use these exclusively, please provide the SI value in parentheses after each value.
- Species names should be italicized (e.g., Homo sapiens).
- Genes, mutations, genotypes, and alleles should be indicated in italics. Use the recommended name by consulting the appropriate genetic nomenclature database, e.g., HUGO for human genes. It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman: v-fes, c-MYC, etc.
- The Recommended International Non-Proprietary Name (rINN) of drugs should be provided.
Figures
If the article is accepted for publication, the author will be asked to supply high-resolution, print-ready versions of the figures. Please ensure that the files conform to our Guidelines for Figure and Table Preparation when preparing your figures for production. After acceptance, authors will also be asked to provide an attractive image to highlight their paper online.
Figure Legends
The aim of the figure legend should be to describe the key messages of the figure, but the figure should also be discussed in the text. An enlarged version of the figure and its full legend will often be viewed in a separate window online, and it should be possible for a reader to understand the figure without switching back and forth between this window and the relevant parts of the text. Each legend should have a concise title of no more than 15 words. The legend itself should be succinct, while still explaining all symbols and abbreviations. Avoid lengthy descriptions of methods.
Tables
All tables should have a concise title. Footnotes can be used to explain abbreviations. Citations should be indicated using the same style as outlined above. Tables occupying more than one printed page should be avoided, if possible. Larger tables can be published as online supporting information. Tables must be cell-based; do not use picture elements, text boxes, tabs, or returns in tables. Please ensure that the files conform to our Guidelines for Figure and Table Preparation when preparing your tables for production.
Multimedia Files and Supporting Information
We encourage authors to submit essential supporting files and multimedia files along with their manuscripts. All supporting material will be subject to peer review, and should be smaller than 10 MB in size because of the difficulties that some users will experience in loading or downloading files of a greater size.
Supporting files should fall into one of the following categories: Dataset, Figure, Table, Text, Protocol, Audio, or Video. All supporting information should be referred to in the manuscript with a leading capital S (e.g., Figure S4 for the fourth supporting information figure). Titles (and, if desired, legends) for all supporting information files should be listed in the manuscript under the heading "Supporting Information."
Supporting files may be submitted in a variety of formats, but should be publication-ready, as these files are not copyedited. All video files should be submitted as AVI or Quicktime files.
6. First-Time Submission of Research Articles
Cover Letter
It is important that you include a cover letter with your manuscript. Please explain why this manuscript is suitable for publication in PLoS Genetics, why will your paper inspire the other members of your field, and how will it drive research forward? You are free to recommend a suitable Associate Editor to handle your submission; however, the editors reserve the right to contact an alternative—either from the board or a guest editor—if it is considered more appropriate (such factors as travel commitments, unavailability, and workload are taken into account).
Electronic Submission
Detailed instructions for submission can be found on the PLoS Genetics Manuscript Submission and Peer Review Web site. For your initial submission, we recommend that you upload your entire manuscript, including tables and figures, as a single PDF file. This will save you time in uploading and allows editors and reviewers to view and/or download your manuscript in one easy step. If you choose to upload files individually, they will be combined into a single PDF file that you must approve at the end of the submission process.
Electronic Formats
Text files can be submitted in the following formats: Word, RTF, or PDF. Any articles that have been prepared in LaTeX will be accepted for review, but only in PDF format. Post acceptance, text files (RTF or Word) of the revised manuscript and tables are required for use in the pre-production and copyediting processes. Graphics files should be submitted in the following formats: EPS, TIFF, or PDF.
Before submission, please consult our Submission Checklist.
7. Submission of Revised Research Articles
If you are invited to submit a revised manuscript, we will ask for an editable text and publication-quality files for display items (figures and tables) at that time. Together with your response to editors?and/or reviewers?comments, please provide an author summary of your work and a striking image or video clip (if one is available).
Author Summary
We ask that all authors of research articles that have been returned for revision include a 150-200 word non-technical summary of the work as part of the revised manuscript immediately following the Abstract. Subject to editorial review and author revision, this short text is published with all research articles as a highlighted text box.
Distinct from the scientific abstract, the author summary should highlight where the work fits in a broader context of life science knowledge and why these findings are important to an audience that includes both scientists and non-scientists. Ideally aimed to a level of understanding of an undergraduate student, the significance of the work should be presented simply, objectively, and without exaggeration.
Authors should avoid the use of acronyms and complex scientific terms and write the text using the first-person voice. Authors may benefit from consulting with a science writer or press officer to ensure they effectively communicate their findings to a general audience.
Examples are available at:
Pseudogenization of a Sweet-Receptor Gene Accounts for Cats' Indifference toward Sugar
A Hybrid Photoreceptor Expressing Both Rod and Cone Genes in a Mouse Model of Enhanced S-Cone Syndrome
Life in Hot Carbon Monoxide: The Complete Genome Sequence of Carboxydothermus hydrogenoformans Z-2901
Striking Image
Authors are encouraged to provide a striking image or multimedia clip to accompany their article, if one is available. The image (or video clip) will be considered as cover art and/or for publication as a ‘featured image?or article highlight on our Web site. Before resubmission, please consult our Checklist for Revised Submissions.
8. Outline of the Production Process
Once an article has been accepted for publication, the manuscript files are transferred into our production system. Manuscripts are then copyedited by professional copyeditors who correspond directly with the authors concerning queries and corrections. Once the article has been typeset, PDF proofs are generated so that authors can approve all editing and layout. The prompt return of proofs by authors will expedite the production process.
Articles are published online weekly, before a complete issue is assembled each month. PLoS Genetics aims to publish Research Articles within a month of acceptance, after copyediting, formatting, and proofreading. Authors can also have an Early Online Release version of their work posted immediately upon acceptance into our production system to allow rapid access to their work.
9. Other Types of Articles
The front section of PLoS Genetics is a forum for the publication of articles of broad interest to the genetics and genomics community. PLoS Genetics welcomes Correspondence from readers related to a PLoS Genetics paper or an important genetics topic of the day. These communications are short (less than 600 words) and subject to peer review. We will publish selected letters every month. Alternatively, readers may offer comments related to a paper by submitting an eLetter.
Interviews, Reviews, and Special Reports in the front section of PLoS Genetics are by invitation and the open-access publication fee does not apply. If you have a suggestion for a topic or an author, however, we are happy to consider the idea. Please contact the editors (plosgenetics [at] plos.org).
PLoS Genetics welcomes Correspondence from readers related to a PLoS Genetics paper or an important genetics topic of the day. These communications are short (less than 600 words) and subject to peer review. Alternatively, readers may offer comments related to a paper by using the Reader Response feature.
Editorial Board
PLoS Genetics Editorial Board
For editorial inquiries, please e-mail plosgenetics [at] plos.org
Editor-in-Chief
- Wayne N. Frankel
- The Jackson Laboratory
Bar Harbor, USA
E-mail: wfrankel [at] plos.org
Deputy Editor
- Gregory S. Barsh
- Stanford University
Stanford, USA
Section Editors
- Greg Gibson
- North Carolina State University
Raleigh, USA
Gene Expression Profiling
Natural Variation
- Gil McVean
- University of Oxford
Oxford, UK
Evolutionary Genetics
- Wolf Reik
- The Babraham Institute
Cambridge, UK
Epigenetics
Reviews Editors
- Elizabeth M. C. Fisher
- Institute of Neurology
London, UK
- Nicholas Katsanis
- Johns Hopkins University School of Medicine
Baltimore, USA
- Marcy E. MacDonald
- Massachusetts General Hospital
Boston, USA
- Susan M. Rosenberg
- Baylor College of Medicine
Houston, USA
Interviews Editor
- Jane Gitschier
- University of California, San Francisco
San Francisco, USA
Associate Editors
- Gonçalo Abecasis
- University of Michigan
Ann Arbor, USA
human complex disease: genetic mapping, computational and statistical tools
- Asifa Akhtar
- European Molecular Biology Laboratory
Heidelberg, Germany
dosage compensation, chromatin and transcription, epigenetics
- David B. Allison
- University of Alabama at Birmingham
Birmingham, USA
obesity, quantitative genetics, clinical trials, and statistical and research methodology
- David R. Beier
- Harvard Medical School
Boston, USA
mouse genetics, positional cloning, development, mutagenesis, kidney disease
- Wendy Bickmore
- MRC Human Genetics Unit
Edinburgh, UK
nuclear organisation, genome organisation, chromatin
- Sue Biggins
- Fred Hutchinson Cancer Research Center
Seattle, USA
mitosis, yeast genetics, checkpoints
- William F. Burkholder
- Stanford University
Stanford, USA
DNA replication, microbial stress responses, cell cycle checkpoints
- Vivian G. Cheung
- University of Pennsylvania
Philadelphia, USA
human genetics, genomics, genetics of gene expression
- Andrew G. Clark
- Cornell University
Ithaca, USA
adaptive variation in natural populations, population genetics, evolution, genetic basis of complex disease
- Bruce E. Clurman
- Fred Hutchinson Cancer Research Center
Seattle, USA
cancer biology, cell cycle control, proteolysis
- Orna Cohen-Fix
- National Institute of Diabetes & Digestive & Kidney Diseases
Bethesda, USA
cell cycle regulation, mitosis/cell division, nuclear structure/nuclear architecture, yeast genetics
- Gregory P. Copenhaver
- The University of North Carolina at Chapel Hill
Chapel Hill, USA
meiotic recombination, centromere biology, plant biology
- Emmanouil T. Dermitzakis
- The Wellcome Trust Sanger Institute
Cambridge, UK
population genomics, functional variation, gene expression
- Susan K. Dutcher
- Washington University
St. Louis, USA
Chlamydomonas genetics, ciliary and basal body biology, cytoskeleton, positional cloning, chloroplast genetics
- Joseph R. Ecker
- The Salk Institute for Biological Studies
San Diego, USA
plant genetics, epigenetics, genomics, systems biology
- Anne C. Ferguson-Smith
- University of Cambridge
Cambridge, UK
mammalian developmental genetics and epigenetics, comparative genomics, gene regulation
- Jonathan Flint
- University of Oxford/Wellcome Trust Centre for Human Genetics
Oxford, UK
complex trait genetics (mouse and human), QTL analysis, behavioral genetics, psychiatric genetics
- Claire M. Fraser-Liggett
- University of Maryland School of Medicine
Baltimore, USA
prokaryotic genomics and sequencing, comparative genomics
- Michel Georges
- University of Liège
Liège, Belgium
complex traits, QTL mapping, epigenetics
- Takashi Gojobori
- National Institute of Genetics
Mishima, Japan
evolutionary genetics, population genetics, bioinformatics, genomics-oriented human genetics
- David S. Guttman
- University of Toronto
Toronto, Canada
bacterial evolutionary genetics, evolution of virulence and host specificity, comparative genomics
- James E. Haber
- Brandeis University
Waltham, USA
yeast genetics, recombination, DNA repair, replication
- R. Scott Hawley
- Stowers Institute for Medical Research
Kansas City, USA
meiosis, chromosome pairing, chromosome segregation, mutant screens and mutational analysis in Drosophila, mitosis, chromosome structure
- Yoshihide Hayashizaki
- RIKEN Genomic Sciences Center
Yokohama, Japan
molecular genetics, genomics, transcriptomics, post-genome technology
- Kathleen Kerr
- University of Washington
Seattle, USA
expression arrays, experimental design, statistical methods
- Stuart K. Kim
- Stanford University
Stanford, USA
genomics, systems biology, C. elegans genetics, aging
- Leonid Kruglyak
- Princeton University
Princeton, USA
genetic variation and disease, genomics, gene expression (human, dogs, yeast)
- Suzanne M. Leal
- Baylor College of Medicine
Boston, USA
methods in statistical genetics and genetic epidemiology, population and family-based association studies, linkage analysis
- Jeannie T. Lee
- Massachusetts General Hospital
Boston, USA
sex chromosomes, X and autosomal imprinting, noncoding RNA
- Michael Lichten
- National Cancer Institute
Bethesda, USA
meiosis, recombination, chromosome structure/function
- Trudy F. Mackay
- North Carolina State University
Raleigh, USA
complex trait genetics, QTL mapping, LD mapping, evolutionary genetics
- Harmit S. Malik
- Fred Hutchinson Cancer Research Center
Seattle, USA
eukaryotic mobile elements and host defenses, heterochromatin, molecular evolution, multigene families
- Susan E. Mango
- Huntsman Cancer Institute
Salt Lake City, USA
C. elegans genetics, promoter analysis, genomics, organogenesis and development, epithelium formation
- Jonathan Marchini
- University of Oxford
Oxford, UK
association mapping, statistical methods, human complex disease, population structure
- Ivan Matic
- INSERM U571
Paris, France
prokaryotic genetics, recombination, DNA repair, mutagenesis, evolution, infectious diseases
- Michael T. McManus
- UCSF Diabetes Center
San Francisco, USA
RNA expression arrays, mouse transgenics, mechanisms of small RNA biology
- Mary C. Mullins
- University of Pennsylvania
Philadelphia, USA
zebrafish genetics, positional cloning, developmental genetics
- Harry T. Orr
- University of Minnesota
Minneapolis, USA
mammalian genetics, neurodegeneration, triplet repeat diseases
- Jonathan Pritchard
- University of Chicago
Chicago, USA
population genetics, human population structure, association mapping
- Molly Przeworski
- University of Chicago
Chicago, USA
population genetics, molecular evolution, human evolution, human linkage disequilibrium studies
- Paul M. Richardson
- Department of Energy Joint Genome Institute
Walnut Creek, USA
microbial genomics, sequencing technology
- Derry C. Roopenian
- The Jackson Laboratory
Bar Harbor, USA
immunogenetics, mouse genetics
- Mikkel H. Schierup
- University of Aarhus
Aarhus, Denmark
molecular evolution, comparative genomics, population genetics
- Michael Snyder
- Yale University
New Haven, USA
yeast and human genomics and proteomics, chromosome segregation, morphogenesis, cell cycle
- David L. Stern
- Princeton University
Princeton, USA
evolutionary developmental biology, genetics in non-model insects, genetics, physiology, development and evolution of size, control of polyphenisms, development and genetics of bacterial symbiosis
- Lisa Stubbs
- Lawrence Livermore National Laboratory
Livermore, USA
mammalian genetics, comparative genomics, genome evolution, gene regulation
- Joseph S. Takahashi
- Howard Hughes Medical Institute, Northwestern University
Evanston, USA
mouse genetics and genomics, molecular neuroscience, genetics of behavior, circadian biology
- Barbara J. Trask
- Fred Hutchinson Cancer Research Center
Seattle, USA
mammalian genome organization, cytogenetics, gene families, duplications, cancer genetics, nuclear organization, molecular evolution, gross polymorphism
- David Valle
- Johns Hopkins University School of Medicine
Baltimore, USA
human genetics, disease gene identification, analysis, disease mechanisms and model systems, inborn errors of metabolism, genomics
- Veronica van Heyningen
- MRC Human Genetics Unit
Edinburgh, UK
developmental genetics, human disease and mutational mechanisms, regulation of gene expression, genomic organisation, model organisms, gene-environment interactions
- Bas van Steensel
- Netherlands Cancer Institute
Amsterdam, the Netherlands
chromatin structure and composition, epigenetics, gene regulatory networks, genome-wide mapping techniques
|
刊名字顺( Alphabetical List of Journals):
返回页首 